Business Context and Reporting Period
This Form 8-K Current Report was filed by Harvard Bioscience, Inc. on December 22, 2008, covering events occurring on December 18, 2008. The filing addresses Item 5.02 regarding compensatory arrangements for certain officers.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive employment agreements and does not contain financial performance data.
Material Changes
The primary material change involves the amendment and restatement of employment agreements for the following executives:
- Chane Graziano (Chief Executive Officer)
- David Green (President)
- Susan Luscinski (Chief Operating Officer)
These changes were approved by the Compensation Committee to ensure compliance with or exemption from Section 409A of the Internal Revenue Code regarding deferred compensation.
Guidance, Outlook, and Management Commentary
Management commentary is limited to the rationale for the contract amendments. The principal revisions include:
- Changing post-termination payment provisions from a 12-month payout to a lump-sum payment within 30 days of termination.
- Including a general release of claims as an exhibit to the agreements.
- Clarifying the provision of post-termination health benefits.
- Allowing future amendments to preserve benefits in full compliance with Section 409A.
The filing states that full text of the agreements will be included as exhibits to the Annual Report on Form 10-K for the year ended December 31, 2008. No financial guidance or outlook is provided in this document.
Important Facts for Investors to Verify
- Review the full text of the Amended and Restated Employment Agreements in the upcoming Form 10-K to understand specific compensation terms.
- Confirm the impact of the lump-sum termination payment structure on the company's future cash flow obligations.
- Verify that the changes effectively mitigate tax risks associated with Section 409A non-compliance.